Akèy › Sindrom Sezary
Etid klinik pou Sindrom Sezary ap rekrite nan Etazini
13 etid pou Sindrom Sezary ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Baldwin Park, CA7 etid
- Mountain View, CA5 etid
- New York City, NY4 etid
- Houston, TX4 etid
- Atlanta, GA4 etid
- Boston, MA4 etid
- Pittsburgh, PA3 etid
- Philadelphia, PA3 etid
- Tampa, FL3 etid
- St. Louis, MO3 etid
Pa eta
- Florid3 etid
- Georgia4 etid
- Kalifòni9 etid
- Massachusetts4 etid
- Missouri3 etid
- New Jersey3 etid
- New York5 etid
- Pennsylvania6 etid
- Texas4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07003100A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04930653Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT03011814Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT04256018Registry of Older Patients With Cancer
Ap rekriteEtid obsèvasyon
Laj 65 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT01137825A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT03587844Extracorporeal Photopheresis in Sezary Syndrome
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Dec 30, 2025 · NCT05157581Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 30, 2025 · NCT00177268Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 27, 2025 · NCT01137643Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT04234048Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.